Seladelpar Completed Phase 2 Trials for Homozygous Familial Hypercholesterolaemia (HoFH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02472535
Study to Evaluate the Effects of MBX-8025 in Patients With HoFH